Comparing the Performance of Statistical Adjustment Methods By
  Recovering the Experimental Benchmark from the REFLUX Trial by Keele, Luke et al.
Title: Comparing the Performance of Statistical Adjustment Methods By Recovering the Exper-
imental Benchmark from the REFLUX trial.
Authors: Luke Keele, Stephen O’Neill and Richard Grieve
Affiliation: LSHTM, National University of Ireland Galway, and University of Pennsylvania
Correspondence address: Luke Keele, Associate Professor, University of Pennsylvania, Email:
luke.keele@gmail.com
Abstract
Much evidence in comparative effectiveness research is based on observational studies.
Researchers who conduct observational studies typically assume that there are no unobserv-
able differences between the treated and control groups. Treatment effects are estimated
after adjusting for observed differences between treated and controls. However, treatment
effect estimates may be biased due to model misspecification. That is, if the method of
treatment effect estimation imposes unduly strong functional form assumptions, treatment
effect estimates may be significantly biased. In this study, we compare the performance
of a wide variety of treatment effect estimation methods. We do so within the context of
the REFLUX study from the UK. In REFLUX, after study qualification, participants were
enrolled in either a randomized trial arm or patient preference arm. In the randomized trial,
patients were randomly assigned to either surgery or medical management. In the patient
preference arm, participants selected to either have surgery or medical management. We
attempt to recover the treatment effect estimate from the randomized trial arm using the
data from the patient preference arm of the study. We vary the method of treatment effect
estimation and record which methods are successful and which are not. We apply over 20
different methods including standard regression models as well as advanced machine learn-
ing methods. We find that simple propensity score matching methods perform the worst.
We also find significant variation in performance across methods. The wide variation in
performance suggests analysts should use multiple methods of estimation as a robustness
check.
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1 Introduction
Comparative effectiveness research focuses on evaluating the effects of health care strate-
gies on patient outcomes and includes the evaluation of medical strategies, prevention methods,
diagnostic testing, devices, surgeries and rehabilitative techniques. CER also includes the evalu-
ation of innovations in health care delivery, organization and financing, as well as public health
interventions such as vaccinations. The primary scientific aim of CER is to quantify the causal
effect of an intervention on patient outcomes.1 To learn about effectiveness, one must also con-
sider what would have happened under different circumstances (e.g., if those treated had taken
control). Causal inference in statistics focuses on formulating these questions mathematically,
exploring whether answers can be gleaned from data, and if so, determining how well and with
what statistical methods.
As such, research designs and statistical methods for causal inference form a key part of CER.
While randomized trials can rule out bias from unobserved confounders, results from observational
studies are also a critical part of the evidence base in CER. An observational study is an empirical
comparison of treated and control groups where the objective is to elucidate cause-and-effect
relationships in contexts where it is not feasible to use controlled experimentation and subjects
select their own treatment status.2 In an observational study of treatment effects, analysts
use pretreatment covariates and a statistical adjustment strategy to remove overt differences
in the treated and control groups. Estimated treatment effects from an observational study
can suffer from bias primarily from two sources. The first source of bias is from unmeasured
confounders. In an observational study, the investigator must assume there are no unobservable
differences between the treated and control groups. This assumption is often called “selection on
observables,” since the analyst asserts that there is some set of covariates such that treatment
assignment is random conditional on these covariates.3 Critically, this assumption cannot be
tested with observed data.4
However, even if the selection on observables holds, much can go wrong, since model mis-
specification may be a second source of bias. That is, if the analyst selects a method of statistical
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estimation that lacks flexibility, the treatment effect estimate may be biased due to functional
form misspecficiation. For example, functional form misspecification can arise if a continuous
control variable is modeled as linear when it in fact has a nonlinear association with the outcome.
In general, it would be a tragedy to bias a treatment effect estimate if one is fortunate enough to
be in a situation with no unmeasured confounders. Due to this concern, a large number of flexible
estimation methods for treatment effects have been developed. Here, we conduct an investiga-
tion into the comparative performance of a wide range of estimation methods for observational
study designs. Our research is built on an innovative study design that allows us to benchmark
performance against results from a randomized experiment. We review this study design next.
2 Study Design: RCT Benchmarking
Evaluations of statistical estimation methods for treatment effects in observational studies
typically use two different methods. The most common method is statistical simulation. Simula-
tions allow for precise descriptions of statistical performance, since the truth is known. However,
simulation scenarios require abstracting away from the often messy nature of real applications.
One alternative to simulation is RCT benchmarking. In an RCT benchmark design, the investi-
gator conducts an observational study that is focused on recovering treatment effect estimates
from a randomized trial. That is, the analyst creates a scenario where the estimates from an
observational study can be directly compared to the estimates from a randomized trial. We deploy
this strategy here. Under this design, data from an RCT are used to estimate the benchmark
treatment effect. In the next phase, data from an observational study are used to estimate a
treatment effect that can be compared to the RCT estimate. The observational study part of
the design can be conducted in two ways. First, one can remove the treatment group from the
experimental study and replace it with a control group from a new data source. This design was
used in the well-known Lalonde study.5 Alternatively, the observational study component is based
on an entirely new data source where some units are exposed to the same treatment studied in
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the RCT.6 Our study follows the second template. Next, we describe the study protocol more
specifically.
2.1 REFLUX Study Design
We employ data from a study conducted in the United Kingdom (UK). Here, we review that
study and outline how we use it in our investigation. Gastro-Oseophageal Reflux Disease (GORD)
develops when reflux of the stomach contents cause troublesome symptoms or complications
which adversely affect a patients’ well-being. Standard medical management for patients with
GORD is via Proton Pump Inhibitors (PPIs) to suppress acid reflux. While PPIs are effective, there
is the concern that long-term acid suppression from PPIs may be associated with increased risk of
chronic hypergastrinaemia and gastric cancer. One alternative treatment to PPIs is laparoscopic
surgery. However, surgical management, while minimally invasive, carries risk of side effects, such
as infection.
To compare the effectiveness of these two treatment plans, investigators conducted REFLUX,
a multicenter RCT, designed to estimate the effectiveness of laparoscopic surgery for patients
with moderately severe GORD. In the study, patients were randomly assigned to medical man-
agement or laparoscopic surgery.7,8 REFLUX was not just an RCT, however, as it also included
a concurrent parallel patient preference arm.7 Both arms of the study included patients from
the same 21 hospitals in the UK over the same time period (2001-4). All study participants
were asked whether they would consent to participate in the RCT, and those who agreed were
randomly assigned to either medical management or surgery. The patients who chose not to
participate in the RCT were asked to join the study in the patient preference arm. These patients
were then treated according to their preference for either medical management or surgery.
Both arms of the study used the same pragmatic design, and recruited patients according to
minimal inclusion criteria including: the patient was already having medical management with
PPI, and the recruiting clinician was uncertain as to whether surgery or medical management
would be more beneficial. Ineligible patients or those who did not consent to participate were
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excluded. In both arms of the study, patients were asked to complete a baseline questionnaire
which included disease-specific and generic measures of health status. We focus on two primary
endpoints. The first endpoint is EQ-5D, a standardized measure of health status developed by
the EuroQol Group. We focused on EQ-5D measured at 3 months after surgery. We use this
outcome measured at 3 months to minimize the effects of missing outcome data. The second
endpoint we use is a quality of life measure focused specifically on reflux symptoms. The study
enrolled 810 participants. A total of 357 patients were enrolled into the RCT (179 assigned to
medicine, 178 to surgery) and 453 in the preference study (192 selected medicine, 261 selected
surgery).
One strength of the REFLUX study is that it meets recently developed criteria to ensure
that RCT and non-randomized study (NRS) results are comparable.9 More specifically, as part
of REFLUX the two arms used a common eligibility criteria and treatment strategy. Moreover,
outcome measurement and follow-up periods were identical for both arms of REFLUX. This
harmonization ensures that differences between the RCT and NRS estimates are not a result of
differing study protocols.
We use the REFLUX study for RCT benchmarking in the following way. First, we use the
patients enrolled in the RCT arm to estimate the experimental benchmark for the two outcome
measures. We then seek to estimate the same effect using the patient preference arm. We
estimate the effect of surgery by comparing those who selected to have surgery to those who
selected medical management. To estimate the effect within the non-randomized study (NRS),
we control for baseline covariates to make these two groups comparable. We then compare the
estimate from the NRS to the RCT and test whether they different significantly. In our study, we
seek to understand whether the difference between the NRS and RCT estimates is a function of
the treatment effect estimation method we use. Next, we review approaches to and estimation
methods for treatment effect estimates in a NRS.
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3 Approaches to Statistical Adjustment for Observed Confounders
In our study, we adjust for observed confounders in the observational arm of the design and
test whether the NRS estimates are close to the estimates from the RCT. As we noted above,
analysts can apply a wide variety of statistical methods to adjust for observed confounders. In
our study, we employ many different statistical adjustment methods. Our goal is to understand
whether some methods of statistical adjustment perform better in this setting than others. Here,
we outline the three broad approaches to statistical adjustment that we will compare. First, we
define some notation and the necessary identification assumptions needed in the NRS component
of REFLUX.
We assume patients in the REFLUX NRS (indexed by i = 1, . . . , n) form the population,
that the treatment is binary (Zi = 1 (surgery), Zi = 0 (control), and we observe an outcome
variable Yi. Next, we outline the potential outcomes framework.10,11 Prior to treatment, each
patient has two potential responses: (Yi(1), Yi(0)). The outcomes that we actually observe are
a function of potential outcomes and treatment assignment: Yi = ZiYi(1) + (1− Zi)Yi(0). We
also have a matrix of observed, pretreatment covariates, Xi. For each patient, there is possibly
an unobserved covariate ui. Our notation implicitly assumes that the stable unit treatment value
assumption (SUTVA) holds.12 SUTVA is comprised of the two following components: 1) the
treatment levels of Z (1 and 0) adequately represent all versions of the treatment and 2) a
subject’s outcomes are not affected by other subjects’ exposures. The first component of SUTVA
is often referred to as the consistency assumption in the epidemiology literature. The second
component of SUTVA rules out a subject’s outcomes being affected by other subjects’ exposures.
In general, it is difficult to conceive of how the selection of surgical versus non-surgical care for
one patient could affect outcomes for other patients even within the same hospital.
In an NRS, we also invoke additional assumptions that we describe as “selection on ob-
servables.” Under the selection on observables assumption, the analyst asserts that treatment
assignment is random conditional on a set of observed covariates.3 Formally we assume that
6
treatment assignment only depends on observed data:
Pr(Zj = 1|Yi(1), Yi(0),Xi, ui) = Pr(Zi = 1|Xi).
and the probability of treatment is strictly greater than zero and less than one over the support
of Zi:
0 < Pr(Zi) < 1
Under these two assumptions, there are three broad approaches to statistical adjustment.
3.1 Outcome Focused Methods
The dominant approach to statistical adjustment focuses on modeling the outcome. Here,
the analysts builds a statistical model for the conditional expectation of Yi given Zi and Xi:
E(Yi|Zi, Xi). The goal is to estimate the causal effect of Zi on Yi while controlling for observed
confounders. Using a model for the outcome has long been the dominant approach and has
traditionally employed methods such as linear or logistic regression. Though as we outline below,
a wide variety of more flexible estimation methods can be employed.
3.2 Treatment Focused Methods
The primary alternative to outcome modeling is modeling the treatment assignment process.
That is, if the true probability of treatment (the propensity score) is known, one can use the
propensity score to estimate treatment effects.13 Since, the true propensity score is typically
unknown, the investigator estimates a model for the propensity score, which is a model for the
conditional expectation of Zi given Xi: E(Zi|Xi). The estimated propensity score can be used
with either weighting or matching estimators for treatment effect estimation. Alternatively, many
matching methods do not use the propensity score but instead use a direct measure of covariate
distance such as the Mahalanobis distance.14,15 However, these matching methods also model
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E(Zi|Xi) instead of E(Yi|Zi, Xi). Critically, under this approach, statistical adjustment is done
without reference to outcomes.
3.3 Outcome–Treatment Focused Methods
More recently, a class of statistical adjustment methods have been developed which model
both the outcome and treatment. Under this approach, a model for the treatment assignment and
two outcome models are combined to obtain a single treatment effect estimate. This approach
is often referred to as doubly robust, since it will consistently estimate the treatment effect
when either the propensity score model is correctly specified or the outcome models are correctly
specified.16
3.4 Estimation Methods
For each of the three broad approaches outlined above, estimation methods are required
for one or more conditional expectation functions. That is, typically, one is either estimating
a model for the outcome, treatment, or both. A very large number of methods can be used
to estimate these models. As we noted above, the simplest approach is to use either linear or
logistic regression. However, these models are based on simple functional forms that impose strong
linearity and additivity assumptions. The danger is that bias from functional form misspecification
may be significant. Alternatively, a more flexible model such as a generalized additive model or
kernel regression may also be used. The general trend, however, has been to employ increasingly
flexible models usually taken from the literature on statistical prediction and widely referred to as
“machine-learning” (ML) methods. For example, McCaffrey et al17 used generalized boosting to
flexibly model the propensity score, while Hill18 proposes using bayesian additive regression trees
(BART) to flexibly model the outcome. Alternatively, double robust approaches may use a single
ML method such as random forests19 or combine several20 for treatment effect estimation. While
most methods of adjustment rely on a regression model, matching and weighting estimators that
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use covariate distance instead of a propensity score distance, do not estimate a regression model
in the traditional sense. Covariate distance is minimized using an optimization method. This
approach avoids the use of a regression model. Once the matching or weighting is complete, a
simple nonparametric estimator such as the signed rank tests may then be employed to estimate
the treatment effect. However, a regression based model may also be used to estimate the
treatment effects after matching or using weights.21
As we outlined above, we vary the approach to statistical adjustment in the NRS arm of the
REFLUX study. To that end, we use all three approaches: outcome, treatment, or double robust.
We also vary the estimation methods used for each of the approaches. While, there are an almost
endless number of methods we could employ, we focused on the most prominent approaches, but
also let available software options inform our choices. Broadly, we selected a set of ML methods
and then a set of methods that are widely available in Stata or R.
First, we selected three highly flexible machine learning methods. Specifically, we selected
Bayesian additive regression trees. BART was originally designed for statistical prediction,22 but is
an example of a ML method being used for statistical adjustment under selection on observables.23
We use the version of BART that only models outcomes. Recent work has incorporated treatment
assignment models into BART.24 The second ML method we selected was generalized random
forests (GRF).25 While GRF is similar to BART in that it implements a flexible model for the
outcome, under GRF there is also a flexible model for the treatment assignment process; as such it
is doubly robust. Finally, we also selected a method that uses a Super Learner (SL) combined with
Targeted Maximum Likelihood Estimation (TMLE).20,26,27 Under SL, the analyst selects among
a set of prediction methods—learners—that will then be combined in an ensemble. The set of
learners selected by the investigator are used to make out-of-sample predictions through cross-
validation. The predictions from each learner are combined according to weights that minimize
the squared-error loss from predictions to observations. These weights are then used to combine
the fitted values from each learner when fit to the complete data. Then TMLE is applied to
produce an estimate of the ATE or ATT. We used three different learners: (1) random forests,
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(2) lasso, and (3) generalized boosting.
While statistical adjustment methods based on ML have received considerable attention as
of late,28 simpler methods are much more commonly used. To that end, we also applied several
other methods for statistical adjustment. In selecting additional methods for comparison, we used
software availability to guide our choices. That is, we first used the options made available in
Stata. In Stata, one can estimate treatment effects via either matching or weighting using the
teffects command. The teffects command allows for four different forms of statistical adjustment
via: (1) regression adjustment, (2) propensity score weighting, (3) augmented propensity score
weighting, (4) propensity score weighting and regression adjustment. The last category is a form
of a double robust estimator. Stata also includes matching estimators. We used the Stata com-
mands for propensity score matching (teffects psmatch) and nearest neighbor matching (teffects
nnmatch). Finally, Stata includes an option to match with additional regression adjustment after
matching. We added this method of adjustment as well.
Next, we included a set of statistical adjustment methods that are available in R. In R, we
estimated treatment effects via regression adjustment, propensity score weighting, augmented
propensity score weighting, and a doubly robust estimator based on propensity score weighting.
However, R also includes a wide variety of matching estimators that are unavailable in Stata. To
that end, we included three different forms of matching. First, we included a standard match
on the propensity score using an optimal form of matching.29 Next, following the guidelines in30
we matched using the Mahalanobis distance with a propensity score caliper. Finally, we used a
more advanced method of matching known as cardinality matching.31 Cardinality matching seeks
to target a specified set of balance constraints and will trim the sample to meet those balance
targets. In a recent comparison of statistical methods via simulation, cardinality matching had the
best properties relative to a variety of matching estimators.32 For all three matching methods, we
estimated treatment effects in two ways. First, we estimated the treatment effect as the average
difference in matched pair outcomes. Second, we estimated the treatment effect via a regression
model using the matched data, but also included additional covariates for bias correction.
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In sum, we use a variety of statistical methods for estimating treatment effects within the
context of REFLUX. The methods we use are based on all three approaches and include simple
methods such as regression to more advanced methods based on machine learning. We seek
to draw conclusions about whether more complex methods appear to produce treatment effect
estimates that are closer to the experimental benchmark in REFLUX. The primary strength of
this research design is that it allows us to evaluate statistical adjustment methods in a realistic
setting.
4 Data Analysis
Next, we harmonized the data analysis between the RCT arm and observational study arms
of REFLUX, to further ensure that the estimates are comparable.9 This harmonization is critical,
since there was noncompliance with the trial protocol in the RCT arm. Specifically, in the RCT
arm, of the 178 patients that were assigned to surgery 67 received medical management; whereas
in the medical management arm, ten patients crossed over to surgery.
However, in the NRS arm of REFLUX a similar pattern occurred. While patients initially
selected their course of treatment, due to feedback from clinicians, some changed their course
of treatment. In the NRS arm, while 261 selected surgical treatment, 43 patients later changed
to medical management. Moreover, of the 192 patients that selected medical management, six
later crossed-over and had surgery. Given that in both arms of REFLUX, there was crossover,
the correct comparison is that of intention-to-treat (ITT) effects. The ITT estimate, in both
arms, is the effect of assignment to treatment rather than exposure to the treatment. While we
could seek to estimate the effect of treatment exposure in both the RCT and the NRS that would
require additional assumptions.
In our analysis, we conduct a formal statistical comparison between the ITT estimate from
each statistical estimator and the experimental benchmark. More formally, for each method of
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adjustment, we then estimated the following measure of standardized bias:
τˆrct − τˆobs
SDrct=0
where τˆrct is the estimate from the original RCT, τˆobs is the estimated treatment effect from the
NRS, and SDrct=0 is the standard deviation from the control group in the RCT. This is a standard
measure for studies of this type.33 Thus, we report how far the estimates from observational study
methods are from the RCT estimate. We also include 95% confidence intervals for this measure
of standardized bias. We also compared methods using mean-squared error (MSE). We calculated
MSE as the length of the 95% confidence interval added to the bias-term squared.
Table 1: Balance Table for Patient Preference Arm in REFLUX Study
Treated Mean Control Mean Std. Diff. p-value
Age 45.21 49.04 -0.32 0.00
Female 0.38 0.43 -0.11 0.34
Duration of Symptoms 27.63 27.53 0.03 0.82
BMI 59.56 41.92 0.28 0.01
Employment Category 1 0.64 0.53 0.23 0.04
Employment Category 2 0.16 0.10 0.15 0.17
Employment Category 3 0.20 0.37 -0.37 0.00
Education Category 1 0.56 0.51 0.10 0.34
Education Category 2 0.27 0.24 0.09 0.43
Education Category 3 0.17 0.25 -0.22 0.05
Heartburn Symptoms 49.08 73.96 -1.08 0.00
Gastro Symptoms 47.76 60.75 -0.59 0.00
Nausea Symptoms 77.42 90.20 -0.77 0.00
Reflux Activity Score 74.47 87.14 -0.88 0.00
Gastro Symptoms 1 74.80 83.84 -0.45 0.00
Health Quality Score 0.68 0.75 -0.31 0.00
Note: Std. Diff: the difference in means divided by the standard deviation be-
fore adjustment.
In the NRS, we adjust for a large number of baseline covariates collected for all patients.
These covariates include age, sex, BMI, employment status (3 categories), age left education,
initial EQ-5D, and 5 scales that measured reflux symptoms including heartburn and nausea. The
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data also contain indicators for the 21 centers that participated in the study.
Table 1 contains balance statistics by treatment in the NRS arm of REFLUX. We find clear
differences between the patients that selected surgery versus medical management. For example,
surgical patients had notably lower health quality scores and very different scores on the symptom
scales. Table 2 compares balance between the NRS and RCT arms of the study. In the RCT,
randomization balances observed covariates as expected, while only a few of the covariates are
balanced in the NRS.
Table 2: Balance Table for Patient Preference Arm in REFLUX Study
RCT NRS
Std. Diff. p-value Std. Diff. p-value
Age 0.18 0.11 -0.32 0.00
Female 0.06 0.58 -0.11 0.34
Duration of Symptoms 0.01 0.89 0.03 0.82
BMI 0.09 0.40 0.28 0.01
Employment Category 1 0.11 0.33 0.23 0.04
Employment Category 2 -0.06 0.57 0.15 0.17
Employment Category 3 -0.08 0.49 -0.37 0.00
Education Category 1 0.05 0.63 0.10 0.34
Education Category 2 -0.04 0.74 0.09 0.43
Education Category 3 -0.03 0.80 -0.22 0.05
Heartburn Symptoms -0.08 0.47 -1.08 0.00
Gastro Symptoms -0.05 0.63 -0.59 0.00
Nausea Symptoms 0.06 0.60 -0.77 0.00
Reflux Activity Score -0.03 0.79 -0.88 0.00
Gastro Symptoms 1 0.11 0.33 -0.45 0.00
Health Quality Score 0.01 0.94 -0.31 0.00
Note: Std. Diff: the difference in means divided by the standard
deviation of control group. NRS: Nonrandomized study.
5 Results
Next, we present the results from our analysis. Figure 1 contains the results for the three ML
based methods for estimating treatment effects. For the health status outcome, the confidence
intervals cover zero which implies that the estimated effects from the NRS are indistinguishable
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Figure 1: Bias in statistical estimates for on machine learning methods of statistical adjustment.
Estimates are standardized difference between NRS and RCT treatment effects.
from the RCT estimate. However, for the quality of life outcome, this is only true for the BART
and GRF methods. For the estimate based on TMLE and a Superlearner, the estimated bias
exceeds .2 standard deviations and the 95% confidence interval does not cover zero. To further
investigate why this might be the case, we iterated added additional learners to the Superlearner.
However, this did not improve the estimates. Moreover, while the BART confidence interval does
overlap zero, the estimated bias is nearly .15 standard deviations, which one might denote as
large but not statistically significant.
Next, we report results based on the methods available in Stata. For the health status
outcome, one specific pattern stands out: both matching estimators returns estimates that are
significantly different from the RCT estimate. However, once additional bias reduction is added
via regression adjustment, the matched estimate is no longer statistically different from the RCT
estimate. The source of the bias in these matching methods is straightforward: post-matching
balance checks reveal significant imbalances remain. All the estimates based on weighting have
confidence intervals that cover zero. While this is also true for the estimate based on standard
regression adjustment, this estimate has higher levels of bias than those based on weighting. For
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the quality of life outcome, only the estimate based on augmented propensity score weighting is
close to the RCT estimate. For every other method, the estimated bias is statistically significant.
Here, it is worth noting that additional bias reduction via modeling the outcome after matching
or with the doubly robust estimator is ineffective.
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Figure 2: Bias in statistical estimates based on methods of statistical adjustment available in
Stata. Estimates are standardized difference between NRS and RCT treatment effects
Finally, we report the results using methods in R. For the health status outcome, only the
estimate based on a propensity score match statistically differs from the RCT estimate. Again,
we found that the propensity score match produces large imbalances. However, once we include
additional bias reduction via a regression model, the propensity score matching estimate displays
little bias. In fact, we see across all three matched estimates, adding an outcome model reduces
the bias. Also we find that only the doubly robust estimate overestimates the RCT benchmark.
For the quality of life outcome, we find that two of the matching estimators produce significant
amounts of bias. That is, the estimates from a propensity score and Mahalanobis distance match,
differ significantly from the RCT benchmark. Both matching methods failed to balance key
covariates. However, in both cases, using a regression model after matching produces significant
bias reduction—the estimates are nearly identical to the RCT benchmark. One interesting pattern
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is apparent for cardinality matching. Cardinality matching produces little bias even without
additional regression adjustment, and additional regression adjustment only produces minimal
further bias reduction. Unlike other matching methods, cardinality matching directly targets high
levels of balance at the start of the matching process. Finally, all the estimates based on weighting
produce results that do not differ significantly from the RCT benchmark.
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Figure 3: Bias in statistical estimates based on methods of statistical adjustment available in R.
Point estimates are standardized difference between NRS and RCT estimates.
Next, we provide two broad summaries of the results. Thus far, we have only compared
methods in terms of bias: the difference between the RCT and NRS treatment effect estimates.
Next, we report results using the MSE metric outlined above. Under a MSE criterion, we might
expect treatment assignment focused methods to perform worse, since they do not utilize outcome
information. We calculated MSE as the length of the 95% confidence interval added to the bias-
term squared.
Table 3 contains MSE estimates for each method and both outcomes. For the health status
outcome, MSE estimates are mostly similar, and use of outcome information confers little benefit.
For example, the propensity score match in R has an MSE value of 0.11, which is identical to the
estimate based on a Superlearner and TMLE. The one exception is the propensity score match
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estimates from Stata. For this method, the MSE is double the other methods. For the quality
of life outcome, a few patterns are worth noting. Using regression adjustment in conjunction
with matching produces very large gains in MSE. Second, the propensity score match in Stata is
again the worst performer. Finally, estimates based on machine learning methods, are not clearly
superior to other methods that use outcome information.
Table 3: Mean-Squared Error Comparison Across All Methods and Out-
comes
Health Status Quality of Life
GRF 0.12 11.36
BART 0.08 17.02
SL + TMLE 0.11 37.26
R – Regression Adjustment 0.09 9.81
R – IPW 0.13 14.71
R – AIPW 0.13 14.73
R – Doubly Robust Weight. 0.15 8.78
R – Pscore Match 0.11 71.03
R – Pscore Match + Reg. Adj. 0.09 8.51
R – Covariate Match 0.10 62.49
R – Covariate Match + Reg. Adj. 0.10 8.60
R – Cardinality Match 0.15 10.11
R – Cardinality Match + Reg. Adj. 0.11 9.47
Stata – Regression Adjustment 0.13 43.20
Stata – IPW 0.15 26.73
Stata – AIPW 0.10 9.15
Stata – IPW + Reg. Adj. 0.15 26.73
Stata – PS Match 0.28 174.07
Stata – NN Match 0.10 25.63
Stata – NN Match + Reg. Adj. 0.09 64.81
Note: Cell entries are estimated MSE for each method of adjustment.
Table 4 contains a full summaries of the complete results in terms of bias. In some respects,
the lack of pattern is striking. That is, in each category there are methods that succeeded and
failed. However, modeling the outcome and treatment assignment more often resulted in smaller
amounts of bias. The other clear pattern is that simple propensity score matching estimators
often displayed larger amounts of bias.
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Table 4: Complete Summary of Results Across All Methods and Outcomes
Outcome Model Health Status Quality of Life
Stata – Regression Adjustment F X
R – Regression Adjustment F F
BART F F
Treatment Model
Stata – IPW X F
Stata – AIPW F F
Stata – PS Match X X
Stata – NN Match X X
R – IPW F F
R – AIPW F F
R – Pscore Match X X
R – Covariate Match F X
R – Cardinality Match F F
Outcome and Treatment
Stata – IPW + Reg. Adj. F X
Stata – NN Match + Reg. Adj. F X
R – Doubly Robust Weight. F F
R – Pscore Match + Reg. Adj. F F
R – Covariate Match + Reg. Adj. F F
R – Cardinality Match + Reg. Adj. F F
R – GRF F F
R – SL + TMLE F X
Note: A X indicates NRS estimate was significantly biased. A F indicates NRS estimate did
not significantly differ from RCT estimate.
6 Conclusions
REFLUX used an innovative design to enroll patients in either a randomized or patient pref-
erence arm. This study design harmonized key aspects of the study to ensure high levels of
comparability between the two arms of the study. In this manuscript, we exploited this design
to study methods of statistical adjustment for treatment effect estimation. By harmonizing the
design and and analysis, we can isolate whether any bias in the effect estimates is due to the
method of statistical adjustment.
Next, we review the broad lessons that can be drawn from the statistical analysis. First,
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ML based methods of statistical adjustment are not fool proof. For the second outcome, two
of the ML methods displayed significant or nearly significant levels of bias. Second, we found
that simpler matching estimators tended to display significant levels of bias. In both Stata
and R, propensity score matching performed poorly in almost every scenario. As we noted above,
propensity score based matching methods generally failed to produce acceptable levels of balance.
This points to a key weakness in propensity score matching. If the initial match fails to produce
acceptable levels of balance, the analyst has few options for improvement. The general advice in
the literature is to alter the specification of the propensity score model.34–37 In our experience, this
is rarely successful. More advanced matching methods allow the investigator to improve balance
directly through propensity score calipers or through balance constraints.38–41 As we observed,
additional regression adjustment reduces this bias, since regression adjusts the treatment effect
estimate by the amount of residual imbalance. Next, propensity score weighting methods in Stata
underperformed those in R. For the second, outcome the results from Stata displayed significant
levels of bias, while those in R did not. This is due to the fact that the match in Stata is a greedy
method, while the match in R was based on an optimal matching method. Our results agree
with recent arguments in the literature against propensity score matching.42 Finally, the more
advanced match based on cardinality matching performed well for both outcomes even without
additional bias reduction using regression models. This result complements the simulation based
results where cardinality matching also tended to outperform other alternatives.32
The variation in results does, however, suggest one important conclusion: analysts should
typically estimate effects using more than one method of statistical adjustment. The variation
we found was not related to approach or estimation method. As such, it behooves researchers
to check that the results are not dependent on the method of statistical adjustment. It is our
sense that most studies only use a single method of statistical adjustment, and this leaves study
results vulnerable to the possibility that results are statistical method dependent. One option
is an approach suggested in.43 They recommend an analysis plan where the study first employs
a method of matching or weighting to prioritize balance according to subject matter expertise.
19
These results are then checked against estimates from ML methods that do not use prioritization
and utilize outcome information. This form of analysis plan builds in variation in the methods of
statistical adjustment.
20
References
1M. A. Hernán, “The c-word: Scientific euphemisms do not improve causal inference from
observational data,” American journal of public health, vol. 108, no. 5, pp. 616–619, 2018.
2W. G. Cochran, “The planning of observational studies of human populations,” Journal of
Royal Statistical Society, Series A, vol. 128, no. 2, pp. 234–265, 1965.
3 B. Barnow, G. Cain, and A. Goldberger, “Issues in the analysis of selectivity bias,” in Evaluation
Studies (E. Stromsdorfer and G. Farkas, eds.), vol. 5, pp. 43–59, San Francisco, CA: Sage,
1980.
4 C. F. Manski, Identification For Prediction And Decision. Cambridge, Mass: Harvard University
Press, 2007.
5 R. Lalonde, “Evaluating the econometric evaluations of training programs,” American Economic
Review, vol. 76, pp. 604–620, September 1986.
6M. Fralick, A. S. Kesselheim, J. Avorn, and S. Schneeweiss, “Use of health care databases to
support supplemental indications of approved medications,” JAMA internal medicine, vol. 178,
no. 1, pp. 55–63, 2018.
7 A. M. Grant, S. M. Wileman, C. R. Ramsay, L. Bojke, M. J. Sculpher, M. M. Kilonzo, L. D. Vale,
J. J. Francis, A. G. Mowat, Z. H. Krukowski, et al., “The effectiveness and cost-effectiveness
of minimal access surgery amongst people with gastro-oesophageal reflux disease–a uk collab-
orative study,” Health Technology Assessment, vol. 12, no. 31, p. 1, 2008.
8 A. Grant, C. Boachie, S. Cotton, R. Faria, L. Bojke, D. Epstein, C. Ramsay, B. Corbacho,
M. Sculpher, Z. Krukowski, et al., “Clinical and economic evaluation of laparoscopic surgery
compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of
multicentre randomised trial (the reflux trial).,” Health technology assessment, vol. 17, no. 22,
p. 1, 2013.
9 S. Lodi, A. Phillips, J. Lundgren, R. Logan, S. Sharma, S. R. Cole, A. Babiker, M. Law, H. Chu,
D. Byrne, et al., “Effect estimates in randomized trials and observational studies: comparing
apples with apples,” American journal of epidemiology, vol. 188, no. 8, pp. 1569–1577, 2019.
10 J. Neyman, “On the application of probability theory to agricultural experiments. essay on
principles. section 9.,” Statistical Science, vol. 5, pp. 465–472. Trans. Dorota M. Dabrowska
and Terence P. Speed (1990)., November 1923.
11D. B. Rubin, “Estimating causal effects of treatments in randomized and nonrandomized stud-
ies,” Journal of Educational Psychology, vol. 6, no. 5, pp. 688–701, 1974.
12D. B. Rubin, “Which ifs have causal answers,” Journal of the American Statistical Association,
vol. 81, pp. 961–962, December 1986.
13 P. R. Rosenbaum and D. B. Rubin, “The central role of propensity scores in observational
studies for causal effects,” Biometrika, vol. 76, pp. 41–55, April 1983.
21
14 P. C. Mahalanobis, “On the generalized distance in statistics,” Proceedings of the National
Institute of Sciences (Calcutta), vol. 2, no. 1, pp. 49–55, 1936.
15D. B. Rubin, “Bias reduction using mahalanobis-metric matching,” Biometrics, vol. 36, no. 2,
pp. 293–298, 1980.
16D. O. Scharfstein, A. Rotnitzky, and J. M. Robins, “Adjusting for nonignorable drop-out using
semiparametric nonresponse models,” Journal of the American Statistical Association, vol. 94,
no. 448, pp. 1096–1120, 1999.
17D. F. McCaffrey, G. Ridgeway, and A. R. Morral, “Propensity score estimation with boosted
regression for evaluating causal effects in observational studies.,” Psychological methods, vol. 9,
no. 4, pp. 403–425, 2004.
18 J. Hill, C. Weiss, and F. Zhai, “Challenges with propensity score strategies in a high-dimensional
setting and a potential alternative,” Multivariate Behavioral Research, vol. 46, no. 3, pp. 477–
513, 2011.
19 S. Wager and S. Athey, “Estimation and inference of heterogeneous treatment effects using
random forests,” Journal of the American Statistical Association, no. just-accepted, 2017.
20 S. E. Sinisi, E. C. Polley, M. L. Petersen, S.-Y. Rhee, and M. J. van der Laan, “Super learning:
an application to the prediction of hiv-1 drug resistance,” Statistical applications in genetics
and molecular biology, vol. 6, no. 1, 2007.
21 G. W. Imbens, “Matching methods in practice: Three examples,” Journal of Human Resources,
vol. 50, no. 2, pp. 373–419, 2015.
22H. A. Chipman, E. I. George, R. E. McCulloch, et al., “Bart: Bayesian additive regression
trees,” The Annals of Applied Statistics, vol. 4, no. 1, pp. 266–298, 2010.
23 J. L. Hill, “Bayesian nonparametric modeling for causal inference,” Journal of Computational
and Graphical Statistics, vol. 20, no. 1, 2011.
24 P. R. Hahn, J. S. Murray, and C. M. Carvalho, “Bayesian regression tree models for causal
inference: regularization, confounding, and heterogeneous effects.” Unpublished Manuscript,
2017.
25 S. Athey, J. Tibshirani, and S. Wager, “Generalized Random Forests,” ArXiv e-prints, Oct.
2016.
26M. J. Van der Laan and S. Rose, Targeted learning: causal inference for observational and
experimental data. Springer Science & Business Media, 2011.
27 S. Gruber, R. W. Logan, I. Jarrín, S. Monge, and M. A. Hernán, “Ensemble learning of inverse
probability weights for marginal structural modeling in large observational datasets,” Statistics
in medicine, vol. 34, no. 1, pp. 106–117, 2015.
22
28 V. Dorie, J. Hill, U. Shalit, M. Scott, and D. Cervone, “Automated versus do-it-yourself meth-
ods for causal inference: Lessons learned from a data analysis competition,” arXiv preprint
arXiv:1707.02641, 2017.
29 P. R. Rosenbaum, “Optimal matching for observational studies,” Journal of the American
Statistical Association, vol. 84, pp. 1024–1032, December 1989.
30 P. R. Rosenbaum, Observational Studies. New York, NY: Springer, 2nd ed., 2002.
31 J. R. Zubizarreta, R. D. Paredes, and P. R. Rosenbaum, “Matching for balance, pairing for
heterogeneity in an observational study of the effectiveness of for-profit and not-for-profit high
schools in chile,” The Annals of Applied Statistics, vol. 8, no. 1, pp. 204–231, 2014.
32M. Resa and J. R. Zubizarreta, “Evaluation of subset matching methods and forms of covariate
balance,” Statistics in medicine, vol. 35, no. 27, pp. 4961–4979, 2016.
33 V. C. Wong, J. C. Valentine, and K. Miller-Bains, “Empirical performance of covariates in
education observational studies,” Journal of Research on Educational Effectiveness, vol. 10,
no. 1, pp. 207–236, 2017.
34 J. Lee and T. D. Little, “A practical guide to propensity score analysis for applied clinical
research,” Behaviour research and therapy, vol. 98, pp. 76–90, 2017.
35 V. S. Harder, E. A. Stuart, and J. C. Anthony, “Propensity score techniques and the assess-
ment of measured covariate balance to test causal associations in psychological research.,”
Psychological methods, vol. 15, no. 3, p. 234, 2010.
36W. Leite, Practical propensity score methods using R. Thousand Oaks, CA: Sage Publications,
2016.
37 S. Guo and M. W. Fraser, Propensity score analysis: Statistical Methods and Applications.
Thousand Oaks, CA: Sage, 2015.
38 P. R. Rosenbaum, Design of Observational Studies. New York: Springer-Verlag, 2010.
39 J. R. Zubizarreta, “Using mixed integer programming for matching in an observational study of
kidney failure after surgery,” Journal of the American Statistical Association, vol. 107, no. 500,
pp. 1360–1371, 2012.
40 S. D. Pimentel, R. R. Kelz, J. H. Silber, and P. R. Rosenbaum, “Large, sparse optimal matching
with refined covariate balance in an observational study of the health outcomes produced by
new surgeons,” Journal of the American Statistical Association, vol. 110, no. 510, pp. 515–527,
2015.
41 A. Diamond and J. S. Sekhon, “Genetic matching for estimating causal effects: A general mul-
tivariate matching method for achieving balance in observational studies,” Review of Economics
and Statistics, vol. 95, no. 3, pp. 932–945, 2013.
42 G. King and R. Nielsen, “Why propensity scores should not be used for matching,” Political
Analysis, vol. 27, no. 4, pp. 435–454, 2019.
23
43 L. J. Keele and D. S. Small, “Comparing covariate prioritization via matching to machine learn-
ing methods for causal inference using five empirical applications.” Unpublished Manuscript,
2019.
24
